These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38272087)

  • 1. Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions.
    Chi L; YifeiYang ; Bian X; Gao B; Tu P; Ru H; Lu K
    Sci Total Environ; 2024 Apr; 919():169603. PubMed ID: 38272087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.
    Gonzalez FJ; Jiang C; Patterson AD
    Gastroenterology; 2016 Nov; 151(5):845-859. PubMed ID: 27639801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis.
    Qin D; Pan P; Lyu B; Chen W; Gao Y
    Biomed Pharmacother; 2024 Aug; 177():116942. PubMed ID: 38889641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
    Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
    Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease.
    Shi Z; Chen G; Cao Z; Wu F; Lei H; Chen C; Song Y; Liu C; Li J; Zhou J; Lu Y; Zhang L
    J Agric Food Chem; 2021 Apr; 69(13):3982-3991. PubMed ID: 33755449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
    Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.
    Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK
    J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Low-Dose Non-Caloric Sweetener Consumption on Gut Microbiota in Mice.
    Uebanso T; Ohnishi A; Kitayama R; Yoshimoto A; Nakahashi M; Shimohata T; Mawatari K; Takahashi A
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587159
    [No Abstract]   [Full Text] [Related]  

  • 11. Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice.
    Huang Y; Chen H; Chen J; Wu Q; Zhang W; Li D; Lu Y; Chen Y
    Phytomedicine; 2024 Oct; 133():155919. PubMed ID: 39153277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.
    Zhang L; Xie C; Nichols RG; Chan SH; Jiang C; Hao R; Smith PB; Cai J; Simons MN; Hatzakis E; Maranas CD; Gonzalez FJ; Patterson AD
    mSystems; 2016; 1(5):. PubMed ID: 27822554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-induced obesity requires farnesoid X receptor.
    Parséus A; Sommer N; Sommer F; Caesar R; Molinaro A; Ståhlman M; Greiner TU; Perkins R; Bäckhed F
    Gut; 2017 Mar; 66(3):429-437. PubMed ID: 26740296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism.
    Xu W; Kong Y; Zhang T; Gong Z; Xiao W
    J Sci Food Agric; 2023 Feb; 103(3):1283-1293. PubMed ID: 36087337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.
    Singh AB; Dong B; Xu Y; Zhang Y; Liu J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):358-371. PubMed ID: 30580099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.